本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Denali Therapeutics Inc.

14.60
+1.4511.03%
盤後14.700.1000+0.68%16:40 EDT
成交量:186.81萬
成交額:2,686.78萬
市值:21.20億
市盈率:-5.68
高:14.66
開:13.41
低:13.41
收:13.15
資料載入中...
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]